These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge. Chia SC, Leung PS, Liao CP, Huang JH, Lee ST. Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032 [Abstract] [Full Text] [Related]
25. Mutations in the temperature-sensitive murine cytomegalovirus (MCMV) mutants tsm5 and tsm30: a study of genes involved in immune evasion, DNA packaging and processing, and DNA replication. Sweet C, Ball K, Morley PJ, Guilfoyle K, Kirby M. J Med Virol; 2007 Mar; 79(3):285-99. PubMed ID: 17245727 [Abstract] [Full Text] [Related]
26. DNA immunization confers protection against murine cytomegalovirus infection. González Armas JC, Morello CS, Cranmer LD, Spector DH. J Virol; 1996 Nov; 70(11):7921-8. PubMed ID: 8892915 [Abstract] [Full Text] [Related]
28. A 27 amino acid coding region of JE virus E protein expressed in E. coli as fusion protein with glutathione-S-transferase elicit neutralizing antibody in mice. Seif SA, Morita K, Igarashi A. Virus Res; 1996 Jul; 43(1):91-6. PubMed ID: 8822638 [Abstract] [Full Text] [Related]
29. Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes. Fuchs W, Rziha HJ, Lukàcs N, Braunschweiger I, Visser N, Lütticken D, Schreurs CS, Thiel HJ, Mettenleiter TC. J Gen Virol; 1990 May; 71 ( Pt 5)():1141-51. PubMed ID: 1693164 [Abstract] [Full Text] [Related]
30. Different antibody response to a neutralizing epitope of human cytomegalovirus glycoprotein B among seropositive individuals. Ayata M, Sugano T, Murayama T, Sakamuro D, Takegami T, Matsumoto Y, Furukawa T. J Med Virol; 1994 Aug; 43(4):386-92. PubMed ID: 7525866 [Abstract] [Full Text] [Related]
31. Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins. Cranmer LD, Clark CL, Morello CS, Farrell HE, Rawlinson WD, Spector DH. J Virol; 1996 Nov; 70(11):7929-39. PubMed ID: 8892916 [Abstract] [Full Text] [Related]
32. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides. Chassot S, Lambert V, Kay A, Godinot C, Roux B, Trepo C, Cova L. Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963 [Abstract] [Full Text] [Related]
36. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Osterrieder N, Wagner R, Brandmüller C, Schmidt P, Wolf H, Kaaden OR. Virology; 1995 Apr 20; 208(2):500-10. PubMed ID: 7747423 [Abstract] [Full Text] [Related]
37. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY, Luo L, Wainberg MA, Li Y. Biol Chem; 1999 Mar 20; 380(3):353-64. PubMed ID: 10223338 [Abstract] [Full Text] [Related]
38. Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein. Kropff B, Mach M. J Gen Virol; 1997 Aug 20; 78 ( Pt 8)():1999-2007. PubMed ID: 9267000 [Abstract] [Full Text] [Related]
39. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Roehrig JT, Bolin RA, Kelly RG. Virology; 1998 Jul 05; 246(2):317-28. PubMed ID: 9657950 [Abstract] [Full Text] [Related]
40. Characterization of neutralizing monoclonal antibodies to murine cytomegalovirus. Farrell HE, Shellam GR. J Gen Virol; 1990 Mar 05; 71 ( Pt 3)():655-64. PubMed ID: 2155998 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]